HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hon-Kan Yip Selected Research

NPHS2 protein

1/2022Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat.
12/2019Preactivated and disaggregated shape-changed platelets protect kidney against from ischemia-reperfusion injury in rat through attenuating inflammation reaction.
3/2019Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.
1/2019Cerebro- and renoprotective activities through platelet-derived biomaterials against cerebrorenal syndrome in rat model.
1/2018Inducible pluripotent stem cell-derived mesenchymal stem cell therapy effectively protected kidney from acute ischemia-reperfusion injury.
1/2017Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan.
8/2016Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hon-Kan Yip Research Topics

Disease

72Inflammation (Inflammations)
01/2022 - 11/2004
71Myocardial Infarction
08/2020 - 01/2002
42Ischemia
04/2022 - 03/2005
38Fibrosis (Cirrhosis)
02/2022 - 09/2008
33Infarction (Infarctions)
04/2022 - 09/2003
26ST Elevation Myocardial Infarction
05/2021 - 05/2006
25Heart Failure
04/2022 - 01/2006
23Reperfusion Injury
04/2021 - 04/2012
23Ischemic Stroke
02/2020 - 04/2006
22Shock
01/2022 - 01/2008
20Stroke (Strokes)
07/2021 - 01/2003
16Chronic Limb-Threatening Ischemia
01/2022 - 01/2012
16Thrombosis (Thrombus)
11/2017 - 01/2002
14Chronic Renal Insufficiency
04/2022 - 11/2009
13Cardiogenic Shock
11/2018 - 03/2005
12Brain Infarction
07/2021 - 03/2007
11Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 03/2005
11Neoplasms (Cancer)
10/2021 - 06/2012
10Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
09/2021 - 09/2008
9Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
10/2021 - 12/2012
9Pathologic Constriction (Stenosis)
01/2017 - 01/2003
9Pulmonary Arterial Hypertension
05/2016 - 03/2008
8Hypoxia (Hypoxemia)
01/2020 - 01/2014
8Cardiovascular Diseases (Cardiovascular Disease)
11/2017 - 03/2005
8Sepsis (Septicemia)
10/2017 - 01/2003
7Carotid Stenosis (Carotid Artery Stenosis)
01/2020 - 09/2005
7Body Weight (Weight, Body)
01/2017 - 03/2007
7Diabetes Mellitus
01/2015 - 02/2006
6Cardio-Renal Syndrome
04/2022 - 11/2016
6Brain Edema (Cerebral Edema)
01/2022 - 02/2016
6Unstable Angina
07/2006 - 07/2005
5Chronic Kidney Failure (Chronic Renal Failure)
12/2021 - 02/2013
5Acute Kidney Injury (Acute Renal Failure)
10/2021 - 01/2003
5Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2018 - 03/2015
5Lung Injury
01/2018 - 07/2011
5Acute Coronary Syndrome
05/2016 - 09/2003
4Osteonecrosis (Kienbock's Disease)
01/2022 - 11/2016
4Left Ventricular Dysfunction
05/2021 - 01/2011
4Atherosclerosis
01/2019 - 07/2007

Drug/Important Bio-Agent (IBA)

68Proteins (Proteins, Gene)FDA Link
04/2022 - 08/2010
60Biomarkers (Surrogate Marker)IBA
04/2022 - 08/2005
35Caspase 3 (Caspase-3)IBA
09/2021 - 07/2011
29MelatoninIBA
02/2022 - 03/2013
29Matrix Metalloproteinases (MMPs)IBA
10/2021 - 07/2011
25salicylhydroxamic acid (SHAM)IBA
01/2021 - 01/2011
22Cytochromes c (Cytochrome c)IBA
10/2021 - 09/2008
17CreatinineIBA
04/2022 - 11/2007
16CollagenIBA
08/2020 - 07/2011
15erucylphosphocholineIBA
12/2021 - 01/2008
12Therapeutic UsesIBA
04/2019 - 06/2010
12omega-Chloroacetophenone (Mace)IBA
11/2017 - 03/2005
11Oxygen (Dioxygen)IBA
07/2021 - 02/2016
11Exenatide (Byetta)FDA Link
01/2021 - 10/2013
11ErythropoietinFDA Link
01/2020 - 10/2010
10InterleukinsIBA
01/2019 - 05/2007
10Messenger RNA (mRNA)IBA
05/2015 - 08/2010
10C-Reactive ProteinIBA
01/2014 - 11/2004
9Doxorubicin (Adriamycin)FDA LinkGeneric
09/2021 - 12/2015
9MonocrotalineIBA
01/2016 - 03/2008
8DNA (Deoxyribonucleic Acid)IBA
04/2022 - 01/2016
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2008
8AntioxidantsIBA
01/2019 - 07/2012
8CholesterolIBA
01/2019 - 01/2012
7NPHS2 proteinIBA
01/2022 - 08/2016
7Connexin 43 (Connexin43)IBA
01/2019 - 03/2007
6Tacrolimus (Prograf)FDA LinkGeneric
05/2021 - 06/2012
6Coloring Agents (Dyes)IBA
04/2021 - 10/2002
6Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 07/2011
6Rosuvastatin Calcium (Crestor)FDA Link
01/2019 - 07/2012
6Clopidogrel (Plavix)FDA Link
10/2017 - 07/2004
6Losartan (Cozaar)FDA LinkGeneric
06/2009 - 01/2007
5Brain Natriuretic Peptide (Natrecor)FDA Link
04/2022 - 02/2006
5Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2021 - 02/2011
5Sitagliptin Phosphate (Januvia)FDA Link
01/2021 - 09/2013
5Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2021 - 03/2013
5MetalsIBA
05/2016 - 07/2007
5Tirofiban (Aggrastat)FDA Link
11/2009 - 09/2003
5P-SelectinIBA
03/2006 - 11/2003
4sacubitril and valsartan sodium hydrate drug combinationIBA
04/2022 - 08/2019
4Streptozocin (Streptozotocin)FDA Link
01/2022 - 03/2007
4CytokinesIBA
10/2021 - 07/2011
4TNF Receptor-Associated Factor 6 (TRAF6)IBA
10/2021 - 12/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 05/2011
4Cadherins (E-Cadherin)IBA
01/2021 - 08/2016
4N 30IBA
01/2021 - 04/2012
4PropylthiouracilFDA Link
01/2019 - 09/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 07/2011

Therapy/Procedure

97Therapeutics
04/2022 - 05/2003
51Percutaneous Coronary Intervention
05/2021 - 01/2002
24Ligation
10/2021 - 03/2009
12Catheters
01/2018 - 10/2003
11Extracorporeal Shockwave Therapy
01/2022 - 01/2010
10Stents
05/2016 - 10/2005
9Punctures
10/2021 - 12/2012
8Cell- and Tissue-Based Therapy (Cell Therapy)
04/2020 - 08/2008
7Nephrectomy
01/2022 - 01/2015
5Transplantation
01/2020 - 03/2008
5Drug-Eluting Stents
05/2016 - 07/2010
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2016 - 05/2007
4Intravenous Injections
01/2020 - 01/2011